These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10023648)

  • 21. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
    Barton EN; Morgan AG; Burden RP
    West Indian Med J; 1997 Jun; 46(2):57-9. PubMed ID: 9260536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for early incremental dialysis with continuous ambulatory peritoneal dialysis.
    Nolph KD
    Nephrol Dial Transplant; 1998; 13 Suppl 6():117-9. PubMed ID: 9719217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urea kinetics and when to commence dialysis.
    Tattersall J; Greenwood R; Farrington K
    Am J Nephrol; 1995; 15(4):283-9. PubMed ID: 7573184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
    Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
    ASAIO J; 1993; 39(3):M566-8. PubMed ID: 8268600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What we have learned about uremia from peritoneal dialysis.
    Nolph KD
    ASAIO J; 1992; 38(4):745-50. PubMed ID: 1450467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease.
    Fukui H; Hara S; Hashimoto Y; Horiuchi T; Ikezoe M; Itami N; Kawabe M; Kawanishi H; Kimura H; Nakamoto Y; Nakayama M; Ono M; Ota K; Shinoda T; Suga T; Ueda T; Fujishima M; Maeba T; Yamashita A; Yoshino Y; Watanabe S;
    Ther Apher Dial; 2004 Feb; 8(1):56-61. PubMed ID: 15128021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup.
    Frankenfield DL; Prowant BF; Flanigan MJ; Frederick PR; Bailie GR; Helgerson SD; Rocco MV
    Kidney Int; 1999 May; 55(5):1998-2010. PubMed ID: 10231465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure.
    Obrador GT; Pereira BJ
    Am J Kidney Dis; 1998 Mar; 31(3):398-417. PubMed ID: 9506677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adequacy in dialysis: intermittent versus continuous therapies.
    Misra M; Nolph KD
    Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight deficit in patients on continuous ambulatory peritoneal dialysis.
    Tzamaloukas AH; Murata GH; Servilla KS; Hoffman RM
    Am J Kidney Dis; 2002 May; 39(5):1068-77. PubMed ID: 11979352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. We Use Kt/V Urea as a Measure of Adequacy of Peritoneal Dialysis.
    Bargman JM
    Semin Dial; 2016 Jul; 29(4):258-9. PubMed ID: 27081745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics and dosing predictions for daily haemofiltration.
    Leypoldt JK; Jaber BL; Lysaght MJ; McCarthy JT; Moran J
    Nephrol Dial Transplant; 2003 Apr; 18(4):769-76. PubMed ID: 12637647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of urea and creatinine kinetics in predicting CAPD outcome.
    Campbell D; Fritsche C; Brandes J
    Adv Perit Dial; 1992; 8():79-83. PubMed ID: 1361859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adequacy of peritoneal dialysis: does kt/v have the same predictive value as in HD? A multicenter study.
    De Alvaro F; Bajo MA; Alvarez-Ude F; Vigil A; Molina A; Coronel F; Selgas R
    Adv Perit Dial; 1992; 8():93-7. PubMed ID: 1361862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.
    Leong SC; Sao JN; Taussig A; Plummer NS; Meyer TW; Sirich TL
    J Am Soc Nephrol; 2018 Jul; 29(7):1992-1999. PubMed ID: 29728422
    [No Abstract]   [Full Text] [Related]  

  • 37. Once upon a time in dialysis: the last days of Kt/V?
    Vanholder R; Glorieux G; Eloot S
    Kidney Int; 2015 Sep; 88(3):460-5. PubMed ID: 26061543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KT/V: the denominator dilemma.
    Lindholm B; Waniewski J; Weryński A
    Pol Merkur Lekarski; 2003 Oct; 15(88):311-5. PubMed ID: 14974355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodialysis and the elderly patient: potential advantages as to quality of life, urea generation, serum creatinine, and less interdialytic weight gain.
    Avram MR; Pena C; Burrell D; Antignani A; Avram MM
    Am J Kidney Dis; 1990 Oct; 16(4):342-5. PubMed ID: 2220783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysis dose and frequency.
    Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
    Nephrol Dial Transplant; 2005 Feb; 20(2):285-96. PubMed ID: 15598667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.